Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Longitudinal changes in sickness absence and disability pension, and associations between disability pension and disease-specific and contextual factors and functioning, in people with multiple sclerosis.
Hypoxia-like tissue injury and glial response contribute to Balo concentric lesion development.
[Multiple Sclerosis and Commensal Gut Flora].
Expression of IL-1β in rhesus EAE and MS lesions is mainly induced in the CNS itself.
Construct validity of the walk ratio as a measure of gait control in people with multiple sclerosis without mobility aids.
Natalizumab Therapy Modulates miR-155, miR-26a and Proinflammatory Cytokine Expression in MS Patients.
Safety and efficacy of dimethyl fumarate in multiple sclerosis: a multi-center observational study.
Risk of Premenopausal and Postmenopausal Breast Cancer among Multiple Sclerosis Patients.
ST8SIA2 promotes oligodendrocyte differentiation and the integrity of myelin and axons.
Astrocyte-mediated infantile-onset leukoencephalopathy mouse model.
Safety of secukinumab in the treatment of psoriasis.
Injectable Disease Modifying Agents in Multiple Sclerosis: Pattern of Medication Use and Clinical Effectiveness.
Disability-Specific Atlases of Gray Matter Loss in Relapsing-Remitting Multiple Sclerosis.
Safety and tolerability of fingolimod in patients with relapsing-remitting multiple sclerosis: results of an open-label clinical trial in Italy.
The role of the wnt canonical signaling in neurodegenerative diseases.
Immunological treatment of multiple sclerosis.
[Cytology of cerebrospinal fluid : Standards, importance and modern methods].
Cellular and Molecular Mechanisms Underpinning Macrophage Activation during Remyelination.
Giant nerves in chronic inflammatory polyradiculoneuropathy.
The impact of drugs for multiple sclerosis on sleep.
Common antibiotic might be effective treatment for MS.
Regional differences in interhemispheric structural fibers in healthy, term infants.
Immunological processes related to cognitive impairment in MS.
What is the future of proof of concept studies in multiple sclerosis?
Monoclonal Antibody Therapy for Neuromyelitis Optica Spectrum Disorder: Current and Future.

Pages